FH, S., EF, S., H, E., SM, H., & NM, H. (2025). piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: A step-toward ncRNA-precision. Naunyn-Schmiedeberg's archives of pharmacology, 398(1), 47. https://doi.org/10.1007/s00210-024-03308-z
Chicago Style (17th ed.) CitationFH, Shaker, Sanad EF, Elghazaly H, Hsia SM, and Hamdy NM. "PiR-823 Tale as Emerging Cancer-hallmark Molecular Marker in Different Cancer Types: A Step-toward NcRNA-precision." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 1 (2025): 47. https://doi.org/10.1007/s00210-024-03308-z.
MLA (9th ed.) CitationFH, Shaker, et al. "PiR-823 Tale as Emerging Cancer-hallmark Molecular Marker in Different Cancer Types: A Step-toward NcRNA-precision." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 1, 2025, p. 47, https://doi.org/10.1007/s00210-024-03308-z.